The Indian market is expected to trade higher on Friday tracking positive global cues. India VIX was up by 3.71% from 11.31 to 11.73 levels on Thursday. Volatility spiked to 12.7 zones during the day and paved the way for the bears to completely take over the market. Since it is the beginning of new … Read more
“It is just that we have a strong domestic investor sentiment and about $2 billion per month is the incremental SIP which I think to an extent is ensuring that markets are not really crashing,” says Sudip Bandyopadhyay, Inditrade Capital. Just wanted to understand from you that from the earnings, which sector that you are … Read more
ET Intelligence Group: If the diktat of the National Medical Commission (NMC) mandating doctors to prescribe only generic drugs indeed gets implemented, drug marketing in India is likely to witness five major changes.1. Companies with not-so-strong brands are likely to face the heat.Mid-sized pharma companies having brands that are not in top-ten in their therapies … Read more
Brokerage firm JPMorgan maintained an overweight rating on Godrej Consumer, Morgan Stanley has an overweight rating on Zomato and an overweight rating on Britannia. Macquarie, meanwhile, maintained a neutral rating on Ramco Cement and Jefferies recommends a hold on Torrent Pharma. We have collated a list of recommendations of top brokerage firms from ETNow and … Read more
Benchmark indices ended lower on the last day of May amid negative signals from global markets. The S&P BSE Sensex fell 346 points at 62,622, while the Nifty50 settled at 18,534 levels. Among the sectors, auto gained 0.15%, FMCG was up 0.23%, IT was flat, while bank, metals, and financials dragged. Stocks that were in … Read more
The Nifty managed to close above the support zone of 16,750-17,000, but absence of momentum is hindering an upmove. Technical analysts expect the index to consolidate in 16,450-17,450 range till October F&O expiry. Analysts said stocks such as , , ABB, , Angel One, , and could witness strength in the near term. ASHISH CHATURMOHTA … Read more
The US economy also witnessed substantial issues in its pharma market. In addition to these, manufacturing & exporting countries around the world saw heightened raw material price inflation followed by supply chain disruption. All these affected the margins of the companies deeply. Synopsis Indian pharmaceutical market flattened after the pandemic led to a massive upsurge … Read more